Table 3.
Characteristics of the propensity-matched adjusted groups.
| Variable | No PM (n = 208) | PM (n=52)a | P |
|---|---|---|---|
| Predicted probability | 0.64 ± 0.26 | 0.64 ± 0.25 | NS |
| Age (years) | 65.2 ± 13.4 | 66.9 ± 13.6 | NS |
| Female gender (%) | 41.8 | 42.6 | NS |
| Diabetes (%) | 20.1 | 25 | NS |
| Previous time on RRT (years) | 5.06 ± 4.4 | 5.8 ± 4.6 | NS |
| Coronary heart disease (%) | 46.2 | 49.8 | NS |
| Previous stroke (%) | 16.3 | 23.5 | NS |
| Smoker (%) | 11.5 | 17.3 | NS |
| Neoplastic disease (%) | 7.7 | 15.4 | NS |
| Peripheral vascular disease (%) | 21.5 | 28.8 | NS |
| COPD (%) | 6.2 | 9.6 | NS |
| Functional status | |||
| Karnofsky* 1 (%) | 35.9 | 30.8 | NS |
| Karnofsky* 2 (%) | 36.8 | 40.4 | NS |
| Karnofsky* 3 (%) | 21.2 | 22 | NS |
| Karnofsky* 4 (%) | 7.7 | 5.3 | NS |
*As in Table 1.
aAll patients in this group had the PM implanted while on RRT.